Mesoblast (MESO) FCF Margin Growth (3y) (2019 - 2023)
Mesoblast (MESO) FCF Margin Growth (3y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -83,775.00 |
| Mar 31, 2023 | 11,797.00 |
| Dec 31, 2022 | -70,349.00 |
| Sep 30, 2022 | 18,724.00 |
| Jun 30, 2022 | 34,558.00 |
| Mar 31, 2022 | 126,179.00 |
| Dec 31, 2021 | -68,196.00 |
| Sep 30, 2021 | 103,344.00 |
| Jun 30, 2021 | 60,929.00 |
| Mar 31, 2021 | 72,831.00 |
| Dec 31, 2020 | -111,262.00 |
| Sep 30, 2020 | -42,449.00 |
| Jun 30, 2020 | 408,916.00 |
| Mar 31, 2020 | 189,325.00 |
| Dec 31, 2019 | 583,014.00 |
| Sep 30, 2019 | 493,816.00 |
| Jun 30, 2019 | -90,301.00 |
| Mar 31, 2019 | -146,118.00 |